The Department of Health and Human Services under Robert F. Kennedy Jr. has taken unprecedented steps to change how vaccines ...

The Subject Expert Committee (SEC) under the COVID-19 division of the Central Drugs Standard Control Organization (CDSCO) has ...

A revamped U.S. vaccine advisory panel, appointed by Health Secretary Robert F. Kennedy Jr., voted 5-1 on Thursday to ...

Writing in JAMA, four former government officials warn that the Trump administration’s involvement in delaying the approval ...

Peter Marks, who headed the FDA’s Center for Biologics Evaluation and Research before being forced to resign in March, said the agency’s new risk-based COVID-19 vaccine framework contradicts the ...

Retail investor chatter around vaccine makers Novavax, Moderna, and Pfizer rose on Wednesday, ahead of a closely watched CDC ...

Respiratory syncytial virus (RSV) causes severe illness in millions of young children each year.1 Globally, it is estimated that over 100 000 children younger than 5 years die each year from RSV; 97% ...

The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...

The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by multiple ...

The vaccine is expected to be commercially ready for the 2025-2026 COVID-19 season. The Food and Drug Administration (FDA) has approved Nuvaxovid ™ (COVID-19 Vaccine, Adjuvanted) for active ...